Medicare Enrolled
Dr. Thomas Reynolds, MD
Internal Medicine · Montebello, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reynolds from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reynolds?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reynolds
Dr. Thomas Reynolds is an internal medicine specialist in Montebello, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reynolds performed 287 Medicare services across 182 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reynolds received a total of $14,348 from 88 pharmaceutical and/or device companies across 761 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reynolds is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 287 Medicare services
$14,348 industry payments
Medicare Practice Summary
Medicare Utilization ↗287
Medicare services
Bottom 30% in CA for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
182
Unique beneficiaries
$129
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
115 | $158 | $589 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
75 | $102 | $380 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
51 | $113 | $416 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $149 | $553 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $68 | $253 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,348
Total received (2018-2024)
Avg $2,050/year across 7 years
Top 7% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
761
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,970 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$378 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,617
2023
$319
2022
$3,158
2021
$2,997
2020
$2,100
2019
$1,967
2018
$2,190
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$169
Alexion Pharmaceuticals, Inc.
$137
ABBVIE INC.
$105
Janssen Biotech, Inc.
$103
E.R. Squibb & Sons, L.L.C.
$80
Regeneron Healthcare Solutions, Inc.
$69
Novartis Pharmaceuticals Corporation
$68
Merck Sharp & Dohme LLC
$65
SOBI, INC
$58
PFIZER INC.
$53
Agios Pharmaceuticals, Inc.
$53
Genentech USA, Inc.
$51
Incyte Corporation
$49
Ipsen Biopharmaceuticals, Inc
$41
Astellas Pharma US Inc
$34
Celgene Corporation
$34
EMD Serono, Inc.
$33
ARRAY BIOPHARMA INC
$32
BeiGene USA, Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$29
Tempus AI, Inc
$29
Gilead Sciences, Inc.
$28
Genmab U.S., Inc.
$28
Exelixis Inc.
$26
Lilly USA, LLC
$26
Daiichi Sankyo Inc.
$26
PUMA BIOTECHNOLOGY, INC.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Legend Biotech USA Inc.
$24
PharmaEssentia USA Corporation
$20
Kite Pharma, Inc.
$18
GlaxoSmithKline, LLC.
$18
Top 3 companies account for 25.4% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$1,288
Novartis Pharmaceuticals Corporation
$980
E.R. Squibb & Sons, L.L.C.
$974
PFIZER INC.
$777
Janssen Biotech, Inc.
$759
Amgen Inc.
$473
Takeda Pharmaceuticals U.S.A., Inc.
$419
Incyte Corporation
$404
Merck Sharp & Dohme Corporation
$404
Seagen Inc.
$387
Astellas Pharma US Inc
$359
Bayer HealthCare Pharmaceuticals Inc.
$353
AstraZeneca Pharmaceuticals LP
$347
Alexion Pharmaceuticals, Inc.
$304
Boehringer Ingelheim Pharmaceuticals, Inc.
$275
Daiichi Sankyo Inc.
$269
GENZYME CORPORATION
$262
Teva Pharmaceuticals USA, Inc.
$259
Lilly USA, LLC
$233
GlaxoSmithKline, LLC.
$228
Genentech USA, Inc.
$206
ARRAY BIOPHARMA INC
$203
Merck Sharp & Dohme LLC
$191
Regeneron Healthcare Solutions, Inc.
$162
Pharmacyclics LLC, An AbbVie Company
$160
INSYS Therapeutics Inc
$152
BeiGene USA, Inc.
$151
Eisai Inc.
$148
Pharmacyclics LLC, an AbbVie Company
$148
Rigel Pharmaceuticals, Inc.
$141
Karyopharm Therapeutics Inc.
$135
Dendreon Pharmaceuticals LLC
$132
PUMA BIOTECHNOLOGY, INC.
$126
EMD Serono, Inc.
$122
Exelixis Inc.
$116
Gilead Sciences, Inc.
$115
Taiho Oncology, Inc.
$107
ABBVIE INC.
$105
Dova Pharmaceuticals
$93
Deciphera Pharmaceuticals Inc.
$93
EISAI INC.
$89
Agios Pharmaceuticals, Inc.
$79
Puma Biotechnology, Inc.
$79
EUSA Pharma (US) LLC
$74
Seattle Genetics, Inc.
$69
GE HealthCare
$67
Clovis Oncology, Inc.
$65
TESARO, Inc.
$63
Foundation Medicine, Inc.
$60
SOBI, INC
$58
Global Blood Therapeutics, Inc.
$51
Secura Bio, Inc.
$50
Epizyme, Inc.,
$44
AVEO Pharmaceuticals, Inc.
$44
Adaptive Biotechnologies Corporation
$41
Ipsen Biopharmaceuticals, Inc
$41
G1 Therapeutics, Inc.
$40
Myovant Sciences Inc.
$40
Kite Pharma, Inc.
$39
SANOFI-AVENTIS U.S. LLC
$38
GE HEALTHCARE
$36
Progenics Pharmaceuticals, Inc.
$33
Stemline Therapeutics Inc.
$32
MEDIVATION FIELD SOLUTIONS LLC
$31
Sobi, Inc
$29
Bayer Healthcare Pharmaceuticals Inc.
$29
Tempus AI, Inc
$29
Genmab U.S., Inc.
$28
TAIHO ONCOLOGY, INC.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
MorphoSys, US Inc.
$25
Legend Biotech USA Inc.
$24
TerSera Therapeutics LLC
$24
Advanced Accelerator Applications
$24
Jazz Pharmaceuticals Inc.
$23
JAZZ PHARMACEUTICALS INC.
$23
Verastem, Inc.
$23
Arrow International, Inc.
$22
Spectrum Pharmaceuticals Inc.
$22
Blueprint Medicines Corporation
$21
PharmaEssentia USA Corporation
$20
Kyowa Kirin, Inc.
$19
ADC Therapeutics America, Inc.
$19
Array BioPharma Inc.
$17
Aurobindo Pharma USA, Inc.
$15
Sirtex Medical Inc
$15
Verity Pharmaceuticals Inc.
$14
Acrotech Biopharma LLC
$11
Top 3 companies account for 22.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CATHETERS - ARROW · CERDELGA · COSELA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Enhertu · Epkinly · FARYDAK · FOLOTYN · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Phesgo · Polivy · Pomalyst · QINLOCK · REBLOZYL · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SYNAGIS · SYNDROS · Stivarga · Sylvant · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · Ultomiris · VERZENIO · VIZIMPRO · Vectibix · Vitrakvi · XALKORI · XOSPATA · XPOVIO · XTANDI · Xermelo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
5,500
Per 100K population
55.8
County median income
$87,760
Nearest hospital
ADVENTIST HEALTH WHITE MEMORIAL MONTEBELLO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reynolds is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reynolds experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Reynolds performed 115 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reynolds receive payments from pharmaceutical companies?
Yes. Dr. Reynolds received a total of $14,348 from 88 companies across 761 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reynolds's costs compare to other internal medicine physicians in Montebello?
Dr. Reynolds's average Medicare payment per service is $129. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reynolds) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Montebello
Browse internal medicine physicians in Montebello ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology